Comments on: CareToLive Writes to Interim FDA Commissioner Dr. Frank Torti http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/ CareToLive | Help Men With Late Stage Prostate Cancer | Provenge Now! Wed, 08 Feb 2012 12:47:32 +0000 http://wordpress.org/?v=2.3.1 By: 6 Articles Discuss Dendreon Stock Manipulation Over the Years | Dendreon Opinion http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-19194 6 Articles Discuss Dendreon Stock Manipulation Over the Years | Dendreon Opinion Tue, 21 Dec 2010 17:48:31 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-19194 [...] CareToLive Writes to Interim FDA Commissioner Dr. Frank Torti – Care to Live (Jan. 2009) [...] […] CareToLive Writes to Interim FDA Commissioner Dr. Frank Torti – Care to Live (Jan. 2009) […]

]]> By: John Malone named Live Nation interim chair | Juicy Celeb Drama Unearthed http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-17865 John Malone named Live Nation interim chair | Juicy Celeb Drama Unearthed Mon, 18 Oct 2010 09:27:48 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-17865 [...] CareToLive Writes t&#959 Interim FDA Official Dr. Frank Torti … [...] […] CareToLive Writes t&#959 Interim FDA Official Dr. Frank Torti … […]

]]> By: John Malone named Live Nation interim chair | Unearth Da Celeb Drama http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-17842 John Malone named Live Nation interim chair | Unearth Da Celeb Drama Sat, 16 Oct 2010 00:32:49 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-17842 [...] CareToLive Writes t&#959 Interim FDA Commissioner Dr. Frank Torti … [...] […] CareToLive Writes t&#959 Interim FDA Commissioner Dr. Frank Torti … […]

]]> By: CTL Attorney Kerry Donahue Gets Pro Bono Award For Provenge Cancer Treatment Advocacy | CareToLive http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-14811 CTL Attorney Kerry Donahue Gets Pro Bono Award For Provenge Cancer Treatment Advocacy | CareToLive Fri, 19 Feb 2010 18:37:07 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-14811 [...] has documented Mr. Scher’s activities and financial concerns (see Sleepless in Asentar and CTL Writes Interim FDA Commissioner Frank Torti). The astonishing fact is FDA went along and helped Scher by leaking his letter as well as follow-up [...] […] has documented Mr. Scher’s activities and financial concerns (see Sleepless in Asentar and CTL Writes Interim FDA Commissioner Frank Torti). The astonishing fact is FDA went along and helped Scher by leaking his letter as well as follow-up […]

]]> By: Placebo - Special Needs [HQ] http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-14074 Placebo - Special Needs [HQ] Sun, 17 Jan 2010 21:54:03 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-14074 [...] CareToLive Writes to Interim FDA Commissioner Dr. Frank Torti … [...] […] CareToLive Writes to Interim FDA Commissioner Dr. Frank Torti … […]

]]> By: Michael Malone http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-8676 Michael Malone Sun, 17 May 2009 12:30:22 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-8676 Genta's Genesense is finally going to be approved, per the leak. Time to invest before the news gets out. The results of "Agenda" will be released at the conference in ASCO '09. Genta’s Genesense is finally going to be approved, per the leak.
Time to invest before the news gets out. The results of “Agenda” will be released at the conference in ASCO ‘09.

]]> By: CareToLive http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-7279 CareToLive Mon, 23 Mar 2009 14:07:43 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-7279 Thanks for your comments, whoever you are. You sound like an FDA PR person who serves the FDA and not the people of America. Either that, or you are one of the conflicted doctors or an investment friend of theirs. Why not say who you are? The FDA has overruled advisory panels before, but never for a drug for a life-threatening condition where they are no other options and the advisory panel decided it met the criteria for FDA approval. The panel voted the treatment safe, 17-0, you cannot get better than that. Even the conflicted doctors vote yes. Dr. Howard Scher let it be know he was worried about other treatments under development so he could not pull the yes lever. He was the ringleader in sabotaging Provenge because he was invested and/or employed by these other treatments under development. The panel voted, many on the panel were more experienced in this type of treatment, and they voted that it showed substantial evidence of efficacy! They voted yes, 13-4, to the Federal regulatory question! You need to know, the FDA answers to Congress and it also answers to the American people. The FDA works for us, we do not work for it. The FDA is captured and plays favorites to the detriment of the patients. The motivation of the FDA is to serve its business relationships. It does not play by the rules set up by Congress. Thanks for your comments, whoever you are. You sound like an FDA PR person who serves the FDA and not the people of America. Either that, or you are one of the conflicted doctors or an investment friend of theirs. Why not say who you are?

The FDA has overruled advisory panels before, but never for a drug for a life-threatening condition where they are no other options and the advisory panel decided it met the criteria for FDA approval. The panel voted the treatment safe, 17-0, you cannot get better than that. Even the conflicted doctors vote yes.

Dr. Howard Scher let it be know he was worried about other treatments under development so he could not pull the yes lever. He was the ringleader in sabotaging Provenge because he was invested and/or employed by these other treatments under development. The panel voted, many on the panel were more experienced in this type of treatment, and they voted that it showed substantial evidence of efficacy! They voted yes, 13-4, to the Federal regulatory question!

You need to know, the FDA answers to Congress and it also answers to the American people. The FDA works for us, we do not work for it. The FDA is captured and plays favorites to the detriment of the patients. The motivation of the FDA is to serve its business relationships. It does not play by the rules set up by Congress.

]]> By: Reliable sciences are the key in medicine http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-7264 Reliable sciences are the key in medicine Sun, 22 Mar 2009 21:55:31 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-7264 Sorry I miss a key word after "the safety" in the above blog, that is effectiveness. Do not forgrt that the motivation of drug developers is different from that of responsible healthcare providers who take care of their patients seriously. Offering an ineffective or unsafe treatment is against their professionalism and medical intergrity. Sorry I miss a key word after “the safety” in the above blog, that is effectiveness. Do not forgrt that the motivation of drug developers is different from that of responsible healthcare providers who take care of their patients seriously. Offering an ineffective or unsafe treatment is against their professionalism and medical intergrity.

]]> By: Reliable sciences are the key in medicine http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-7262 Reliable sciences are the key in medicine Sun, 22 Mar 2009 21:44:46 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-7262 FDA's mission is to ensure the safety of approved drugs or agents. Reliable scientific evidence is the cornerstone. To understand FDA's desicions of approval, one needs to understand sciences first. FDA’s mission is to ensure the safety of approved drugs or agents. Reliable scientific evidence is the cornerstone. To understand FDA’s desicions of approval, one needs to understand sciences first.

]]> By: Adam http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-6968 Adam Mon, 02 Mar 2009 20:53:48 +0000 http://caretolive.com/2009-01-25/caretolive-e-mails-the-interim-fda-commissioner/#comment-6968 This follows a similar story as Genta's n(GNTA) Genasense drug application for the treatment of CLL and Melanoma. It's very sad the FDA continues to thwart the availability of drugs that meet or exceed their primary and secondary endpoints, yet remain unavailable due to the incompetence of the FDA's oncology sector. This follows a similar story as Genta’s n(GNTA) Genasense drug application for the treatment of CLL and Melanoma. It’s very sad the FDA continues to thwart the availability of drugs that meet or exceed their primary and secondary endpoints, yet remain unavailable due to the incompetence of the FDA’s oncology sector.

]]>